Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non- small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy

(2014) HongQing Zhuang et al.   OncoTargets and Therapy

Radiation Recall Pneumonitis Caused by Erlotinib after Palliative Definitive Radiotherapy

(2012) Cem Onal et al.   ONKOLOGIE

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report

(2011) Chen-Hsi Hsieh et al.   BMC CANCER

Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon

(2011) Hiroaki Arakawa et al.   JAPANESE JOURNAL OF RADIOLOGY

A Case of Radiation Recall Pneumonitis Induced by Erlotinib, Which Can be Related to High Plasma Concentration

(2010) Yosuke Togashi et al.   Journal of Thoracic Oncology

Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics

(2010) Chen-Hsi Hsieh et al.   Journal of Translational Medicine

Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors

(2009) Dongryul Oh et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Unusual Tumor Response and Toxicity from Radiation and Concurrent Erlotinib for Non–Small-Cell Lung Cancer

(2008) Akash Nanda et al.   Clinical Lung Cancer